[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"updates-archive-2026-05-22-3":3},{"date":4,"filings":5,"has_more":612,"limit":613,"page":614,"total_count":615},"2026-05-22",[6,14,21,28,35,40,47,54,61,66,72,77,84,91,98,105,112,119,126,133,138,145,150,155,162,167,173,178,185,191,197,204,209,214,220,226,231,236,241,248,255,260,267,272,278,284,289,293,300,305,311,316,323,330,337,342,347,352,358,365,372,378,384,391,398,403,410,417,422,427,434,441,447,454,459,464,471,478,483,488,495,502,509,516,523,530,535,539,544,549,554,560,565,570,577,584,589,594,600,605],{"company_name":7,"filing_date":8,"filing_source":9,"headline":10,"id":11,"stock_code":12,"summary_text":13},"DAM Capital Advisors Ltd","2026-05-22T21:36:40.729000","BSE","FY26 Results: Net Profit Drops 30%, Stock Broking Segment Turns to Loss","6a107f52ecaa861d94929ebb","DAMCAPITAL","- **Profitability Decline**: Net Profit After Tax (PAT) for FY26 fell by 29.96% to ₹72.69 crore from ₹103.78 crore in the previous year.\n- **Segment Underperformance**: The Stock Broking segment reported a significant downturn, swinging from a profit of ₹20.53 crore in FY25 to a loss of ₹5.15 crore in FY26.\n- **Dividend Recommended**: The Board has recommended a Final Dividend of Re. 1 per equity share for the financial year 2025-26, subject to shareholder approval.\n- **Management Change**: Mr. Jateen Doshi will cease to be a Whole Time Director upon completion of his tenure on June 9, 2026, but will continue his employment with the company.\n- **CEO Re-appointment**: The Board approved the re-appointment of Mr. Dharmesh Anil Mehta as the Managing Director & CEO for a further term of 5 years.",{"company_name":15,"filing_date":16,"filing_source":9,"headline":17,"id":18,"stock_code":19,"summary_text":20},"IITL Projects Ltd","2026-05-22T21:36:40.721000","IITL Projects Pivots to New Businesses, Cites Zero Operational Revenue","6a107f39c9cbead9b3c5ff82","531968","*   The Board has approved a proposal to diversify into new service-oriented businesses: brokerage, construction consultancy, and project management.\n*   This move is a response to the company currently generating **no operational revenue** from its business activities, sustaining itself mainly through \"other income.\"\n*   The company states the **\"Estimated amount to be invested\"** in these new business lines is **\"NIL,\"** a highly unusual detail for such a strategic shift.",{"company_name":22,"filing_date":23,"filing_source":24,"headline":25,"id":26,"stock_code":12,"summary_text":27},"Dam Capital Advisors Limited","2026-05-22T21:36:39.827000","NSE","FY26 Results: Profit Dips 30%, Director to Step Down","6a107f4d0c6b4fb98a92b685","• \u003Cb>Profit Plummets:\u003C\u002Fb> Consolidated Net Profit for FY26 fell by 30% to ₹72.69 Crores from ₹103.78 Crores in the previous year.\n• \u003Cb>Stock Broking Loss:\u003C\u002Fb> The Stock Broking segment reported a loss of ₹5.15 Crores, a sharp decline from a profit of ₹20.53 Crores in FY25.\n• \u003Cb>Dividend Declared:\u003C\u002Fb> The Board recommended a final dividend of Re. 1\u002F- per equity share, subject to shareholder approval.\n• \u003Cb>Key Director Steps Down:\u003C\u002Fb> Mr. Jateen Doshi will cease to be a Whole Time Director and Key Managerial Personnel (KMP) effective June 9, 2026.",{"company_name":29,"filing_date":30,"filing_source":24,"headline":31,"id":32,"stock_code":33,"summary_text":34},"Jubilant Foodworks Limited","2026-05-22T21:36:39.818000","Shareholders: Final Call to Claim Unclaimed Dividends!","6a107f36890e096a6fc61854","JUBLFOOD","*   The company has issued a final reminder to shareholders to claim any unpaid or unclaimed dividends.\n*   This action is part of the \"Second 100 days campaign - 'Saksham Niveshak'\" which runs until July 09, 2026.\n*   **Crucially, failure to act will result in the transfer of both the unclaimed dividend amount and the corresponding equity shares** to the government's Investor Education and Protection Fund (IEPF).\n*   Shareholders are urged to update their KYC details and follow the procedure outlined in the communication to prevent the forfeiture of their assets.",{"company_name":15,"filing_date":36,"filing_source":9,"headline":37,"id":38,"stock_code":19,"summary_text":39},"2026-05-22T21:31:41.318000","Auditors Flag 'Going Concern' Risk as Net Worth Turns Negative","6a107e2c5236ec99893a62bb","*   The company is officially no longer considered a \"Going Concern\" by management and auditors, as its net worth is fully eroded and liabilities exceed assets.\n*   Reported a 96% YoY drop in Net Profit to ₹125.23 Lakhs for FY26. The company generated zero revenue from its core operations during the year.\n*   The Board has proposed a strategic pivot into new business lines (brokerage, consultancy) with a stated investment of \"NIL\" to create revenue streams.\n*   The auditor's report, while unmodified, contains a significant \"Emphasis of Matters\" paragraph highlighting the company's severe financial distress.",{"company_name":41,"filing_date":42,"filing_source":9,"headline":43,"id":44,"stock_code":45,"summary_text":46},"Excel Industries Ltd","2026-05-22T21:31:41.168000","FY26 Results: Revenue Grows 12%, but Profits Dip 11%","6a107e33f43b112c8d92795d","EXCELINDUS","*   \u003Cb>Financial Performance:\u003C\u002Fb> For the full year (FY26), Revenue from Operations grew 11.9% year-over-year. However, Profit After Tax (PAT) declined by 11.3% due to a significant increase in expenses, indicating margin pressure.\n*   \u003Cb>Shareholder Dividend:\u003C\u002Fb> The Board has recommended a dividend of ₹13.75 per equity share, maintaining the same payout as the previous year.\n*   \u003Cb>Earnings Per Share (EPS):\u003C\u002Fb> Basic EPS for the year fell to ₹60.19, a decrease of 11.3% from ₹67.87 in the prior year.\n*   \u003Cb>Business Restructuring:\u003C\u002Fb> The company has reorganized its business and will now report as a single operating segment: \"Chemicals\".\n*   \u003Cb>Auditor's Opinion:\u003C\u002Fb> The statutory auditors issued a clean (unmodified) opinion on the financial results.",{"company_name":48,"filing_date":49,"filing_source":9,"headline":50,"id":51,"stock_code":52,"summary_text":53},"Team India Guaranty Ltd","2026-05-22T21:31:41.110000","Board to Meet on May 29 to Approve FY26 Financial Results","6a107e09f35e30561cfffc26","511559","*   A Board of Directors meeting is scheduled for Friday, 29th May 2026.\n*   The primary agenda is to consider and approve the audited financial results for the quarter and financial year ended 31st March 2026.\n*   The trading window for insiders has been closed since 01st April 2026 and will reopen 48 hours after the results are made public.",{"company_name":55,"filing_date":56,"filing_source":9,"headline":57,"id":58,"stock_code":59,"summary_text":60},"VTM Ltd","2026-05-22T21:31:40.901000","Reports Unusual Shifts in Service Costs & KMP Pay","6a107e24c9cbead9b3c5ff7c","532893","*   \u003Cb>Unusual Cost Spike:\u003C\u002Fb> Expenses for services availed from related parties surged 122% YoY to ₹1,336.71 Lakhs for the half-year ended March 31, 2026.\n*   \u003Cb>KMP Pay Drops Sharply:\u003C\u002Fb> Remuneration to Key Management Personnel fell by 65% YoY to ₹76.64 Lakhs, a significant and unexplained decrease for the same period.\n*   \u003Cb>High Dependency:\u003C\u002Fb> A substantial portion of core operations, including 'Purchase of goods' (₹2,423.45 Lakhs) and 'Availing of services', are conducted with related parties.\n*   \u003Cb>Management Change:\u003C\u002Fb> The company appointed a new Chief Financial Officer during the reporting period, with Sri P Senthil Kumar taking over from December 15, 2025.",{"company_name":7,"filing_date":62,"filing_source":9,"headline":63,"id":64,"stock_code":12,"summary_text":65},"2026-05-22T21:31:40.883000","DAM Capital Declares Re. 1 Dividend Despite 30% Profit Drop","6a107e3358d87443453a8164","*   📉 **Profit Slump:** Consolidated Profit After Tax for FY26 fell by 29.96% to ₹72.69 Cr from ₹103.78 Cr in FY25. Basic EPS dropped from ₹14.68 to ₹10.28.\n*   🚩 **Segment Woes:** The Stock Broking segment swung from a profit of ₹20.53 Cr last year to a loss of ₹5.15 Cr this year, driving the overall decline.\n*   💰 **Dividend Declared:** The Board has recommended a final dividend of Re. 1 per equity share, subject to shareholder approval.\n*   🚨 **Weak Quarter:** Q4 FY26 profit was nearly wiped out, falling to just ₹0.21 Cr compared to ₹9.12 Cr in Q4 FY25, indicating a very weak end to the financial year.\n*    boardroom **Management Change:** Mr. Jateen Doshi, Whole Time Director, will step down from the Board on June 9, 2026. Mr. Dharmesh Mehta has been re-appointed as MD & CEO.",{"company_name":67,"filing_date":68,"filing_source":9,"headline":69,"id":70,"stock_code":33,"summary_text":71},"Jubilant FoodWorks Ltd","2026-05-22T21:31:40.871000","Shareholder Alert: Final Call to Claim Unpaid Dividends","6a107e16ecaa861d94929eb4","*   Jubilant has launched a campaign urging shareholders to claim any unpaid\u002Funclaimed dividends as a final reminder.\n*   Shareholders risk the permanent loss of these funds and their underlying shares to the government-managed Investor Education and Protection Fund (IEPF) if they do not take action.\n*   The campaign, \"Second Saksham Niveshak,\" runs from April 01, 2026, to July 09, 2026.\n*   Shareholders are required to update their KYC and bank details to process their claims. This filing is a routine compliance matter and does not reflect on the company's operational health.",{"company_name":15,"filing_date":73,"filing_source":9,"headline":74,"id":75,"stock_code":19,"summary_text":76},"2026-05-22T21:31:40.849000","Board Re-appoints Internal Auditor for FY 2026-27","6a107e0dbf8f716f13002137","• The Board of Directors has re-appointed \u003Cb>M\u002Fs. Sheetal Patankar & Co., Chartered Accountants\u003C\u002Fb>, as the company's Internal Auditor.\n• The re-appointment is for the financial year \u003Cb>2026-2027\u003C\u002Fb>, effective from May 22, 2026.\n• This is a routine governance update and does not indicate any change in business strategy or financial performance.",{"company_name":78,"filing_date":79,"filing_source":24,"headline":80,"id":81,"stock_code":82,"summary_text":83},"Ganesh Infraworld Limited","2026-05-22T21:31:39.831000","₹76.11 Crore Turnkey Contract Terminated","6a107e0a890e096a6fc61847","GANESHIN","*   The company's order book will be reduced by ₹ 76.11 Crores following the termination of a significant contract.\n*   The terminated agreement was a turnkey contract with Shree Sai Nirman Realty for the 'Shree Sai Nirman Dream City' project.\n*   Reason for termination: The client failed to make the work site available, preventing the project from starting.\n*   This is considered a significant negative development and a red flag for investors, impacting future revenue visibility.",{"company_name":85,"filing_date":86,"filing_source":24,"headline":87,"id":88,"stock_code":89,"summary_text":90},"ANI Integrated Services Limited","2026-05-22T21:31:39.791000","Board Approves Internal Auditor Re-appointment","6a107e0ba157653c663a9a13","AISL","*   The Board of Directors has re-appointed **M\u002Fs. Shah Valera & Associates LLP** as the company's **Internal Auditor**.\n*   This decision was made during a board meeting held on **May 22, 2026**.\n*   The re-appointment is a routine governance measure to ensure financial oversight and internal controls.\n*   The filing does not contain any other material financial or operational updates.",{"company_name":92,"filing_date":93,"filing_source":24,"headline":94,"id":95,"stock_code":96,"summary_text":97},"Indian Railway Finance Corporation Limited","2026-05-22T21:31:39.733000","IRFC Secures $1.1 Billion Unsecured Loan for Railway Expansion","6a107e190c6b4fb98a92b67c","IRFC","*   IRFC has signed a loan agreement to raise External Commercial Borrowing (ECB) amounting to the JPY equivalent of USD 1.1 billion.\n*   The facility is a 5-year unsecured loan, signaling strong market confidence in the company's financial health.\n*   The funds were raised from a consortium of major banks: State Bank of India, HDFC Bank, Sumitomo Mitsui Banking Corporation, and DBS Bank.\n*   Proceeds will be used to finance projects supporting the expansion and modernization of India's railway infrastructure.",{"company_name":99,"filing_date":100,"filing_source":24,"headline":101,"id":102,"stock_code":103,"summary_text":104},"RHI MAGNESITA INDIA LIMITED","2026-05-22T21:31:39.724000","Simplifies Corporate Structure with Subsidiary Merger","6a107e10abd16353d20036f1","RHIM","*   The Board has approved the merger of its step-down subsidiary, Intermetal Engineers (India) Private Limited, into its wholly-owned subsidiary, Ashwath Technologies Private Limited.\n*   The primary goal is to simplify the corporate structure, streamline management, and reduce administrative and operational costs.\n*   Post-merger, Ashwath Technologies will become a direct, 100% wholly-owned subsidiary of RHI Magnesita India Limited.\n*   No cash is involved. The transaction is an internal restructuring, and RHI Magnesita India will be issued 10,000 new equity shares in the resulting entity.",{"company_name":106,"filing_date":107,"filing_source":9,"headline":108,"id":109,"stock_code":110,"summary_text":111},"RSC International Ltd","2026-05-22T21:26:41.039000","Auditor Flags 'Going Concern' Risk for Third Time Amid Severe Financial Distress","6a107cfef43b112c8d927959","530179","*   **Revenue Collapse**: Total income for FY26 plummeted by 93.6% year-over-year.\n*   **Negative Net Worth**: The company's net worth has been completely eroded and is now negative, a critical indicator of financial instability.\n*   **Worsening Losses**: Net loss for the year increased by 21.1%, with Basic EPS worsening to ₹(0.55).\n*   **Qualified Audit Opinion**: For the third time, the statutory auditor has issued a qualified opinion, raising significant doubt about the company's ability to continue as a \"going concern\" due to recurring losses and eroded net worth.\n*   **Promoter Dependence**: The company's survival is dependent on the \"infusion of funds from the Promoter Group.\"\n*   **Bleak Outlook**: Management did not create a Deferred Tax Asset, admitting they do not foresee \"Probable Future Taxable Profits,\" which confirms a poor near-term outlook.",{"company_name":113,"filing_date":114,"filing_source":24,"headline":115,"id":116,"stock_code":117,"summary_text":118},"Zee Learn Limited","2026-05-22T21:26:40.809000","Strengthens Governance with New Internal Auditor","6a107cdf5236ec99893a62b5","ZEELEARN","*   \u003Cb>Appointment:\u003C\u002Fb> M\u002Fs. Bhuta Shah & Co. LLP has been appointed as the new Internal Auditor.\n*   \u003Cb>Effective Date:\u003C\u002Fb> The appointment is effective from May 22, 2026.\n*   \u003Cb>Significance:\u003C\u002Fb> This is a key governance move to strengthen internal controls and financial oversight.\n*   \u003Cb>About the Firm:\u003C\u002Fb> Bhuta Shah & Co. LLP is a professional firm founded in 1986 with extensive experience in assurance and advisory services.",{"company_name":120,"filing_date":121,"filing_source":24,"headline":122,"id":123,"stock_code":124,"summary_text":125},"Viceroy Hotels Limited","2026-05-22T21:26:40.628000","FY26 Results: Acquisition Drives Growth Amidst Operational Challenges","6a107d15f35e30561cfffc22","VHLTD","*   Acquired Marriott Executive Apartments for ₹206 Cr; the new segment is performing strongly with 10% RevPAR growth.\n*   **Operational Red Flag:** The Courtyard by Marriott hotel's occupancy plummeted by 20.4% in FY26, causing an 18.8% drop in RevPAR, potentially due to renovation disruptions.\n*   **Financial Red Flag:** Total debt surged over 5x to ₹24,540 Lakhs to fund the acquisition, creating a highly leveraged balance sheet.\n*   The company is a post-insolvency (CIRP) entity; pre-insolvency public shareholders were almost entirely wiped out during the restructuring.\n*   A ₹100+ Cr renovation plan is underway to upgrade existing properties, with Phase I now complete.",{"company_name":127,"filing_date":128,"filing_source":24,"headline":129,"id":130,"stock_code":131,"summary_text":132},"Cello World Limited","2026-05-22T21:26:40.588000","Board Meeting on May 27 to Consider Dividend and Potential Restructuring","6a107cd9c9cbead9b3c5ff72","CELLO","*   The Board of Directors will meet on May 27, 2026, to approve the annual financial results for the year ended March 31, 2026.\n*   A recommendation for a Final Dividend for the financial year 2025-26 will be considered.\n*   The Board will also consider a proposal for a \"Scheme of Arrangement,\" a significant development that could impact the company's structure and shareholder value.",{"company_name":113,"filing_date":134,"filing_source":24,"headline":135,"id":136,"stock_code":117,"summary_text":137},"2026-05-22T21:26:40.400000","Appoints New Internal Auditor","6a107cd9ecaa861d94929eaa","*   Zee Learn has appointed **M\u002Fs. Bhuta Shah & Co. LLP** as its new Internal Auditor, effective May 22, 2026.\n*   The appointment is a standard governance measure intended to strengthen internal controls and financial oversight.\n*   M\u002Fs. Bhuta Shah & Co. LLP is a professional services firm founded in 1986 with nearly four decades of experience.\n*   This disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",{"company_name":139,"filing_date":140,"filing_source":24,"headline":141,"id":142,"stock_code":143,"summary_text":144},"Kolte - Patil Developers Limited","2026-05-22T21:26:40.389000","Strengthens Board and Senior Management","6a107cd458d87443453a8157","KOLTEPATIL","*   The Board has approved the re-appointment of **Mr. Girish Paman Vanvari** as a Non-Executive Independent Director, effective July 29, 2026.\n*   Four individuals have been designated as part of the **Senior Management Personnel (SMP)** to strengthen the management structure, effective May 22, 2026.\n*   The new SMPs include a Chief Development Officer, Chief Human Resource Officer, Chief Business Officer Pune, and a Business Head for Mumbai, indicating a strong focus on these key markets.",{"company_name":113,"filing_date":146,"filing_source":24,"headline":147,"id":148,"stock_code":117,"summary_text":149},"2026-05-22T21:26:40.307000","Key Governance Update: New Internal Auditor Appointed","6a107cdbbf8f716f13002130","• The company has appointed M\u002Fs. Bhuta Shah & Co. LLP as its new Internal Auditor.\n• The appointment is effective from May 22, 2026.\n• Bhuta Shah & Co. LLP is a professional services firm with nearly four decades of experience, founded in 1986.",{"company_name":22,"filing_date":151,"filing_source":24,"headline":152,"id":153,"stock_code":12,"summary_text":154},"2026-05-22T21:26:40.041000","FY26 Results: Profit Dips 30% as Stock Broking Slips into Loss; Re. 1 Dividend Declared","6a107d09890e096a6fc61842","• \u003Cb>Profitability Decline:\u003C\u002Fb> Consolidated Profit After Tax (PAT) fell by 29.96% year-over-year to ₹72.69 Cr for FY26.\n• \u003Cb>Stock Broking Underperforms:\u003C\u002Fb> The Stock Broking segment reported a loss of ₹(5.15) Cr, a sharp reversal from a ₹20.53 Cr profit in the previous year.\n• \u003Cb>Dividend Recommended:\u003C\u002Fb> The Board has proposed a final dividend of Re. 1\u002F- per equity share for FY26, subject to shareholder approval.\n• \u003Cb>Key Management Change:\u003C\u002Fb> Mr. Jateen Doshi, Whole Time Director, will not seek re-appointment after his term ends on June 9, 2026, but will continue his employment with the company.\n• \u003Cb>Leadership Continuity:\u003C\u002Fb> The Board re-appointed Mr. Dharmesh Anil Mehta as MD & CEO for a further 5-year term.",{"company_name":156,"filing_date":157,"filing_source":24,"headline":158,"id":159,"stock_code":160,"summary_text":161},"Valiant Organics Limited","2026-05-22T21:26:40.025000","Proposes Major Restructuring & Exit from Subsidiary","6a107cdd0c6b4fb98a92b673","VALIANTORG","*   The company is seeking shareholder approval via postal ballot to cease its partnership in its material subsidiary, Dhanvallabh Ventures LLP.\n*   This action is linked to a proposed Material Related Party Transaction valued at ₹96.05 Crores.\n*   Shareholders will vote on two resolutions: a Special Resolution for the cessation and an Ordinary Resolution for the transaction.\n*   The voting period is scheduled from May 23, 2026, to June 21, 2026.",{"company_name":120,"filing_date":163,"filing_source":24,"headline":164,"id":165,"stock_code":124,"summary_text":166},"2026-05-22T21:26:40.007000","Q4 FY26 Results: Revenue Up, Profits Down Sharply","6a107cefa157653c663a9a0b","*   **Profitability Plunge:** Q4 Net Profit dropped **39.8%** YoY to ₹6.0 Cr. Full-year PAT fell a staggering **76.5%** YoY.\n*   **Reason for Decline:** The company attributes the drop to higher finance and depreciation costs from expansion and renovation investments.\n*   **Operational Softness:** The core Hospitality segment (Courtyard & Marriott) saw a decline in Occupancy (-280 bps) and RevPAR (-6.1%), while its associated F&B segment revenue fell **10%**.\n*   **Red Flag:** The full-year profit margin collapsed to 12.8% from 56.8% in the previous year, a significant concern despite the company's focus on long-term growth.\n*   **Management Outlook:** Management noted a \"softer business environment\" but expressed confidence that ongoing expansion and renovation will strengthen its long-term position.",{"company_name":168,"filing_date":169,"filing_source":24,"headline":170,"id":171,"stock_code":52,"summary_text":172},"Team India Guaranty Limited","2026-05-22T21:26:39.977000","Board Meeting on May 29 to Approve FY26 Results","6a107cdbabd16353d20036e7","*   A Board Meeting is scheduled to be held on May 29, 2026.\n*   The primary agenda is to approve the Audited Standalone Financial Results for the financial year ended March 31, 2026.\n*   The Board may also consider the recommendation of a dividend.",{"company_name":15,"filing_date":174,"filing_source":9,"headline":175,"id":176,"stock_code":19,"summary_text":177},"2026-05-22T21:21:40.753000","Reports FY26 Results, Ceases to be a 'Going Concern'","6a107bcc0c6b4fb98a92b66e","*   The company's filing explicitly states it has ceased to be a \"Going Concern\" as its net worth is fully eroded and liabilities exceed assets.\n*   For FY26, it reported zero Revenue from Operations. Total Equity is negative at (₹22.97 Lakhs) as of March 31, 2026.\n*   The Board has proposed entering a new line of business (brokerage, consultancy) with an estimated investment of \"NIL\".\n*   The redemption period for preference shares held by its Holding Company, Industrial Investment Trust Limited, has been extended to March 31, 2028.",{"company_name":179,"filing_date":180,"filing_source":9,"headline":181,"id":182,"stock_code":183,"summary_text":184},"Multibase India Ltd","2026-05-22T21:21:40.580000","Profit Plummets Despite Q4 Revenue Growth","6a107bd458d87443453a8152","526169","*   **Q4 FY26 Results:** Net Profit fell sharply by 51.1% to ₹198.73 Lakhs, even as Revenue from Operations grew 11.3% to ₹1,775.60 Lakhs year-over-year.\n*   **Full Year FY26:** Net Profit declined 28.8% to ₹1,042.75 Lakhs, with Basic EPS dropping to ₹8.26 from ₹11.61.\n*   **Profitability Pressure:** The profit decline is attributed to a sharp rise in material costs in Q4 and lower revenue for the full year.\n*   **Exports Slump:** Revenue from exports nearly halved, dropping by 48.6% in FY26.\n*   **No Dividend:** The board did not recommend a dividend for FY26, unlike the previous year.\n*   **New Director:** Appointed Mr. Vimal Mishra, a senior executive from parent company DuPont, as an Additional Director.",{"company_name":186,"filing_date":187,"filing_source":9,"headline":188,"id":189,"stock_code":103,"summary_text":190},"Rhi Magnesita India Ltd","2026-05-22T21:21:40.547000","Announces Merger of Wholly-Owned Subsidiaries","6a107bc3c9cbead9b3c5ff6c","*   The Board has approved a Scheme of Amalgamation to merge two of its wholly-owned step-down subsidiaries.\n*   **Parties Involved:** Intermetal Engineers (India) Pvt. Ltd. will merge into Ashwath Technologies Pvt. Ltd.\n*   **New Structure:** Post-merger, Ashwath Technologies will become a direct, wholly-owned subsidiary of RHI Magnesita India, simplifying the corporate structure by eliminating one layer.\n*   **Rationale:** The merger aims to streamline management, reduce administrative costs, and consolidate operations for greater efficiency.\n*   **Consideration:** No cash is involved. RHI Magnesita India will be issued 10,000 equity shares in the merged entity. The Appointed Date for the scheme is April 01, 2026.",{"company_name":192,"filing_date":193,"filing_source":9,"headline":194,"id":195,"stock_code":124,"summary_text":196},"Viceroy Hotels Ltd","2026-05-22T21:21:40.517000","Q4 Revenue Jumps, But Full-Year Profit Plummets 76.5%","6a107bc0abd16353d20036df","*   **Massive Profit Decline:** Full-year Profit After Tax (PAT) for FY26 plummeted by 76.5% to ₹18.3 Cr from ₹78.0 Cr in FY25, despite a 6.3% rise in annual income.\n*   **Strong Q4 Revenue Growth:** For the quarter ended March 31, 2026 (Q4 FY26), Revenue from Operations grew 35.3% year-over-year (YoY).\n*   **Q4 Profitability Hit:** Despite strong revenue, Q4 PAT fell 39.8% YoY, with PAT margins contracting to 12.4% from 28.2% in the previous year.\n*   **Operational Weakness:** Both core hospitality segments saw a decline in Occupancy rates during Q4 (Courtyard & Marriott: -280 bps; Executive Apartments: -300 bps).\n*   **Management's Explanation:** The company cited higher finance and depreciation costs from expansion and a \"softer business environment\" for the decline in profitability.",{"company_name":198,"filing_date":199,"filing_source":24,"headline":200,"id":201,"stock_code":202,"summary_text":203},"Gujarat Themis Biosyn Limited","2026-05-22T21:21:39.934000","To Acquire Japanese Pharma Co. for ₹1,300 Crore","6a107bb7a157653c663a9a03","GUJTHEM","*   Gujarat Themis has entered into an agreement to acquire 100% of MicroBiopharm Japan Co., Ltd. (MBJ), a pharmaceutical company specializing in fermentation and R&D.\n*   The total consideration for the acquisition is JPY 21.5 Billion (approximately ₹ 1,300 Crores), to be funded through a mix of debt and equity.\n*   This is a strategic move to transform GTBL into a technology-driven Contract Development Manufacturing Organization (CDMO) and expand into the Japanese market.\n*   **Key Risk:** The target company, MBJ, is currently loss-making, with a reported net loss of JPY 210 Million.\n*   The transaction is expected to be completed by September 30, 2026, subject to regulatory approvals.",{"company_name":198,"filing_date":205,"filing_source":24,"headline":206,"id":207,"stock_code":202,"summary_text":208},"2026-05-22T21:21:39.924000","To Acquire Japanese CDMO for ~₹1,300 Crores","6a107bb9890e096a6fc6183a","*   Gujarat Themis Biosyn (GTBL) has entered an agreement to acquire 100% of MicroBiopharm Japan Co., Ltd. (MBJ), a Japanese company specializing in fermentation and CDMO services.\n*   The total consideration is **JPY 21.5 Billion (approximately ₹ 1,300 Crores)**, which will be funded through a mix of debt and equity.\n*   This acquisition is a major strategic step for GTBL to evolve into a technology-driven Contract Development and Manufacturing Organization (CDMO) and enter the Japanese market.\n*   The transaction is expected to be completed by September 30, 2026, subject to regulatory approvals in Japan.\n*   **Red Flag:** The target company's disclosed financials include a negative figure of **JPY -210 million**, potentially indicating a net loss or negative net worth.",{"company_name":192,"filing_date":210,"filing_source":9,"headline":211,"id":212,"stock_code":124,"summary_text":213},"2026-05-22T21:16:41.134000","Acquires Marriott Apts; PAT Plummets 76% on Tax Effect","6a107abbc9cbead9b3c5ff67","*   **FY26 Financials:** Revenue grew 6.3% YoY to ₹14,973 Lakhs, and EBITDA rose 20.6% to ₹4,457 Lakhs.\n*   **Profit Drop:** Profit After Tax (PAT) fell 76.5% to ₹1,832 Lakhs. This was primarily due to a large, one-off tax credit in the previous year (FY25); PBT was actually up 1.9%.\n*   **Major Acquisition:** Acquired Marriott Executive Apartments for ₹206 Cr. This was debt-financed, causing long-term borrowings to surge from ₹4,663 Lakhs to ₹24,539 Lakhs.\n*   **Operational Drag:** The Courtyard by Marriott hotel's occupancy plunged by 2,040 bps due to renovations, causing its RevPar to decline by 18.8%.\n*   **Post-Insolvency Context:** The company recently exited a Corporate Insolvency Resolution Process (CIRP), which resulted in a near-total extinguishment of value for pre-CIRP public shareholders.",{"company_name":215,"filing_date":216,"filing_source":9,"headline":217,"id":218,"stock_code":117,"summary_text":219},"Zee Learn Ltd","2026-05-22T21:16:40.996000","FY26 Results Flagged with 'Going Concern' Warning & Qualified Opinion","6a107ab8ecaa861d94929e9b","*   🚨 **Auditor's Red Flags:** The statutory auditor issued a **Qualified Opinion** on the FY26 results and highlighted a **\"Material Uncertainty Related to Going Concern,\"** casting significant doubt on the company's ability to continue operations.\n*   🧐 **Basis for Qualification:** The auditor's concerns stem from the company's failure to assess the recoverability of over **₹1,11,900 lakhs** in receivables and investments, and not providing for over **₹17,950 lakhs** in invoked corporate guarantees.\n*   📊 **Financial Performance:** While consolidated revenue grew 18% YoY to ₹43,906 lakhs, the core \"Educational services\" segment saw its profit (PBIT) decline. The company's overall profitability was heavily supported by non-cash exceptional items.\n*   ⚠️ **Profit Boosters:** Reported profit was inflated by an exceptional gain of **₹4,057.68 lakhs** from writing back a liability and a **₹773.87 lakhs** interest expense reversal on a related-party loan that was retrospectively made interest-free.\n*   ⚖️ **Management vs. Auditor:** Management remains optimistic about recovery through a new business plan and asset sales, a view not shared or validated by the auditor's report.",{"company_name":221,"filing_date":222,"filing_source":24,"headline":223,"id":224,"stock_code":45,"summary_text":225},"Excel Industries Limited","2026-05-22T21:16:40.611000","FY26 Results: Revenue Grows but Profits Decline Amidst Restructuring","6a107a9ebf8f716f13002122","*   **Financial Performance:** For the year ended March 31, 2026, Revenue from Operations grew 11.91%, but Profit After Tax (PAT) fell by 11.31% due to rising expenses.\n*   **Dividend:** The Board has recommended a dividend of ₹13.75 per share, the same as the previous year, subject to shareholder approval.\n*   **Major Restructuring:** The company has reorganized into a single reportable segment, \"Chemicals,\" which the analysis notes is a red flag as it reduces transparency into its diverse business lines.\n*   **Audit Opinion:** The company received an \"unmodified opinion\" from its auditors, indicating the financial statements present a true and fair view.",{"company_name":168,"filing_date":227,"filing_source":24,"headline":228,"id":229,"stock_code":52,"summary_text":230},"2026-05-22T21:16:40.453000","Board Meeting Scheduled to Approve Annual Financials","6a107a7fa157653c663a99fa","*   A Board Meeting has been scheduled for May 29, 2026.\n*   The primary agenda is to consider and approve the Audited Standalone Financial Results for the financial year ended March 31, 2026.\n*   The announcement of the company's financial performance will follow this meeting.\n*   This filing is a routine intimation and contains no other material financial or operational data.",{"company_name":22,"filing_date":232,"filing_source":24,"headline":233,"id":234,"stock_code":12,"summary_text":235},"2026-05-22T21:16:40.301000","FY26 Results: Profit Dips 30% as Stock Broking Segment Swings to Loss","6a107aa5890e096a6fc61833","*   \u003Cb>Profitability Decline:\u003C\u002Fb> Consolidated Net Profit for FY26 fell by 30% to ₹72.69 Crores, with Basic EPS dropping to ₹10.28 from ₹14.68 in the previous year.\n*   \u003Cb>(Red Flag) Segment Underperformance:\u003C\u002Fb> The Stock Broking segment reported a significant loss of ₹5.15 Crores, a sharp reversal from a ₹20.53 Crore profit in FY25.\n*   \u003Cb>Dividend Recommended:\u003C\u002Fb> The Board has proposed a final dividend of Re. 1 per equity share for the financial year ended March 31, 2026.\n*   \u003Cb>Key Management Change:\u003C\u002Fb> Mr. Jateen Doshi, Whole Time Director, will not seek re-appointment and will step down from the Board. The Board re-appointed Mr. Dharmesh Mehta as MD & CEO.\n*   \u003Cb>New Internal Auditor:\u003C\u002Fb> The Board appointed PricewaterhouseCoopers Services LLP (PwC) as the Internal Auditor for FY 2026-27.",{"company_name":168,"filing_date":237,"filing_source":24,"headline":238,"id":239,"stock_code":52,"summary_text":240},"2026-05-22T21:16:40.297000","Board Meeting to Approve Annual Financial Results","6a107a800c6b4fb98a92b666","*   The Board of Directors will meet on 29 May 2026.\n*   The agenda includes the approval of Audited Standalone Financial Results for the financial year ended 31 March 2026.",{"company_name":242,"filing_date":243,"filing_source":24,"headline":244,"id":245,"stock_code":246,"summary_text":247},"DEE Development Engineers Limited","2026-05-22T21:16:40.256000","Investor & Analyst Plant Visit Scheduled","6a107a84abd16353d20036d8","DEEDEV","*   The company will host a plant visit and group meeting for investors and analysts at its Palwal Plant in Haryana.\n*   The event is scheduled for Thursday, March 28, 2026, from 11:00 am to 3:00 pm.\n*   DEE has explicitly stated that no Unpublished Price Sensitive Information (UPSI) will be shared during the visit.\n*   This filing is an intimation made under SEBI's disclosure regulations.",{"company_name":249,"filing_date":250,"filing_source":9,"headline":251,"id":252,"stock_code":253,"summary_text":254},"Bilcare Ltd","2026-05-22T21:11:40.931000","Board Meeting to Approve FY26 Financial Results","6a10795ff43b112c8d927945","526853","*   A Board Meeting is scheduled for **May 29, 2026**, to consider and approve the audited financial results for the quarter and year ended March 31, 2026.\n*   The trading window for designated persons has been closed from April 1, 2026, and will reopen 48 hours after the financial results are announced.",{"company_name":7,"filing_date":256,"filing_source":9,"headline":257,"id":258,"stock_code":12,"summary_text":259},"2026-05-22T21:11:40.888000","FY26 Profit Falls 30%, Stock Broking Segment Turns to Loss","6a107980bf8f716f1300211d","• Consolidated Profit After Tax (PAT) for FY26 fell by 29.9% to ₹72.69 crore from ₹103.78 crore in FY25.\n• The Stock Broking segment reported a loss of ₹(5.15) crore, a significant swing from a profit of ₹20.53 crore last year.\n• The Board has recommended a final dividend of ₹1 per share, subject to shareholder approval.\n• Whole Time Director Mr. Jateen Doshi will not seek re-appointment to the Board but will continue his employment with the company.\n• Basic Earnings Per Share (EPS) declined to ₹10.28 from ₹14.68 in the previous year.",{"company_name":261,"filing_date":262,"filing_source":9,"headline":263,"id":264,"stock_code":265,"summary_text":266},"GTV Engineering Ltd","2026-05-22T21:11:40.810000","FY26 Results: Profit Soars 29%, But Cash Flow Turns Negative","6a107976a157653c663a99f4","539479","*   **Strong Profitability:** Full-year Profit After Tax (PAT) grew by 28.7% to ₹1,421.76 Lakhs, driven by effective cost management. Basic EPS increased by 28.4% to ₹3.03.\n*   \u003Cb>Cash Flow Red Flag:\u003C\u002Fb> Despite strong reported profits, the company generated a negative Cash Flow from Operations of ₹ -278.73 Lakhs, indicating a major struggle in converting profits into actual cash.\n*   \u003Cb>Working Capital Strain:\u003C\u002Fb> The negative cash flow is primarily caused by a sharp increase in funds blocked in Trade Receivables (which more than doubled) and Inventories (up 64%).\n*   \u003Cb>Filing Correction:\u003C\u002Fb> This is a revised submission to correct a clerical error in the original filing, where the audited results were incorrectly labelled as \"Unaudited\". The financial figures themselves are unchanged.\n*   \u003Cb>Auditor's Opinion:\u003C\u002Fb> The statutory auditor has issued an unmodified opinion (a clean chit) on the annual financial results.",{"company_name":179,"filing_date":268,"filing_source":9,"headline":269,"id":270,"stock_code":183,"summary_text":271},"2026-05-22T21:11:40.740000","FY26 Profit Down 29% Amidst Rising Costs; New Director Appointed","6a107964c9cbead9b3c5ff5f","*   \u003Cb>Profit Plummets:\u003C\u002Fb> Full-year (FY26) Net Profit fell 28.85% to ₹1,042.75 Lakhs. The decline was sharper in Q4, with Net Profit dropping 51.15% YoY despite revenue growth.\n*   \u003Cb>Margin Squeeze:\u003C\u002Fb> A 42.45% surge in Q4 expenses was the primary reason for the significant drop in quarterly profit, indicating severe cost pressures.\n*   \u003Cb>New Director Appointed:\u003C\u002Fb> Mr. Vimal Mishra, a senior professional with experience at DuPont, has been appointed as an Additional Director (Non-Executive).\n*   \u003Cb>EPS Decline:\u003C\u002Fb> Annual Earnings Per Share (EPS) decreased to ₹8.26 from ₹11.61 in the previous year, reflecting the lower profitability.",{"company_name":273,"filing_date":274,"filing_source":9,"headline":275,"id":276,"stock_code":131,"summary_text":277},"Cello World Ltd","2026-05-22T21:11:40.672000","Board to Discuss Final Dividend & Major Restructuring Scheme","6a10795eecaa861d94929e95","• A Board Meeting is scheduled for Wednesday, May 27, 2026, to approve financial results for the year ended March 31, 2026.\n• The Board will consider and recommend a final dividend on Equity Shares for the financial year 2025-26.\n• A significant agenda item is to take on record a \"Scheme\" sanctioned by the NCLT, signaling a material corporate restructuring event.\n• The Board will also fix the \"Effective Date\" for the implementation of this Scheme.",{"company_name":279,"filing_date":280,"filing_source":9,"headline":281,"id":282,"stock_code":246,"summary_text":283},"Dee Development Engineers Ltd","2026-05-22T21:11:40.656000","Schedules Investor Plant Visit; Filing Date Raises Compliance Questions","6a107960abd16353d20036d0","*   Announced a plant visit for investors and analysts at its Palwal, Haryana facility, scheduled for March 28, 2026.\n*   \u003Cb>Red Flag:\u003C\u002Fb> The filing reveals a potential compliance lapse. The letter is dated March 22, but it was digitally signed on May 22, nearly two months after the event occurred, raising concerns about the timeliness of the disclosure.\n*   The company assured that no confidential or Unpublished Price Sensitive Information (UPSI) would be shared during the event.",{"company_name":113,"filing_date":285,"filing_source":24,"headline":286,"id":287,"stock_code":117,"summary_text":288},"2026-05-22T21:11:39.854000","Auditors Raise Major Red Flags on FY26 Results","6a1079a3890e096a6fc6182d","*   Statutory auditors issued a **Qualified Opinion** (a significant red flag) for the 3rd to 5th consecutive time on key issues, citing inability to verify the recoverability of assets worth over ₹1,11,913 lakhs and non-provisioning for invoked corporate guarantees.\n*   Reported Standalone Net Profit of ₹9,056.69 lakhs is substantially inflated by a one-off exceptional gain (₹4,057.68 lakhs) and a related-party interest waiver, masking underlying operational performance.\n*   The company faces a massive, un-provisioned liability of **₹66,284.63 lakhs** from an invoked corporate guarantee, which management has not accounted for in the financials despite the auditor's qualification.\n*   While the core 'Educational services' segment remains profitable, its profit has declined. The other two business segments (Construction and Training) continue to be loss-making.",{"company_name":139,"filing_date":290,"filing_source":24,"headline":188,"id":291,"stock_code":143,"summary_text":292},"2026-05-22T21:11:39.719000","6a1079590c6b4fb98a92b65c","*   The Board has approved a Scheme of Amalgamation to merge two wholly-owned subsidiaries, Kolte-Patil Lifespaces Pvt. Ltd. and Kolte-Patil Smart Spaces Pvt. Ltd., into the parent company.\n*   No new shares will be issued as part of the merger, and there will be no change in the company's shareholding pattern.\n*   The stated rationale is to simplify the corporate structure, improve operational efficiency, and achieve cost savings.\n*   Both subsidiaries are non-operational with 'Nil' turnover, suggesting the move is a corporate housekeeping measure to streamline the organization.",{"company_name":294,"filing_date":295,"filing_source":24,"headline":296,"id":297,"stock_code":298,"summary_text":299},"Fortis Healthcare Limited","2026-05-22T21:06:41.299000","Posts 17% Revenue Growth, Secures Brand Ownership & Expands Footprint","6a107895bf8f716f13002119","FORTIS","*   \u003Cb>Strong Financials:\u003C\u002Fb> Reports a 17.3% YoY increase in revenue from operations to ₹9,128 crores for FY26, driven by 19.1% growth in the Healthcare segment.\n*   \u003Cb>Strategic Brand Acquisition:\u003C\u002Fb> Secured perpetual ownership of the 'Fortis' and 'SRL' brands through court auctions, a major strategic milestone ending long-standing legal issues.\n*   \u003Cb>Inorganic Growth:\u003C\u002Fb> Expanded its hospital network by acquiring People Tree Hospital in Bengaluru and Shrimann Superspecialty Hospital in Jalandhar.\n*   \u003Cb>Shareholder Payout:\u003C\u002Fb> The Board has recommended a final dividend of ₹1.00 per equity share for FY26, subject to shareholder approval.\n*   \u003Cb>Regulatory Overhang:\u003C\u002Fb> Significant legal and regulatory risks remain, including an ongoing SFIO investigation and a potential court-ordered forensic audit into past transactions by erstwhile promoters.",{"company_name":221,"filing_date":301,"filing_source":24,"headline":302,"id":303,"stock_code":45,"summary_text":304},"2026-05-22T21:06:41.108000","Board Proposes Final Dividend of ₹2.75\u002FShare","6a107829c9cbead9b3c5ff59","*   The Board of Directors has recommended a Final Dividend of ₹2.75 per equity share for the financial year ended March 31, 2026.\n*   This dividend payment is subject to the approval of shareholders at the upcoming Annual General Meeting (AGM).\n*   The Record Date and Payment Date will be announced by the company at a later time.",{"company_name":306,"filing_date":307,"filing_source":9,"headline":308,"id":309,"stock_code":298,"summary_text":310},"Fortis Healthcare Ltd","2026-05-22T21:06:41.053000","FY26 Results: Revenue Jumps 17%, Diagnostics Profit Soars 84%","6a107892a157653c663a99ef","*   \u003Cb>Strong FY26 Performance:\u003C\u002Fb> Consolidated revenue grew 17.2% YoY to ₹9,128 Cr, while total segment profit (PBIT) surged by 36% to ₹1,636 Cr.\n*   \u003Cb>Diagnostics Segment Soars:\u003C\u002Fb> The Diagnostics business was a standout, with its profit (PBIT) growing by an exceptional 83.9% and margins expanding significantly from 9.35% to 15.84%.\n*   \u003Cb>Shareholder Payout:\u003C\u002Fb> The Board has recommended a final dividend of ₹1.00 per equity share, subject to shareholder approval.\n*   \u003Cb>Strategic Milestones:\u003C\u002Fb> Completed two hospital acquisitions, secured ownership of the 'Fortis' brand, and successfully resolved the long-pending IHH Healthcare open offer.\n*   \u003Cb>Regulatory Risk:\u003C\u002Fb> The company continues to face significant legal and regulatory investigations related to the actions of its former promoters (pre-2018).",{"company_name":215,"filing_date":312,"filing_source":9,"headline":313,"id":314,"stock_code":117,"summary_text":315},"2026-05-22T21:06:40.913000","FY26 Results Posted Amidst Major Audit Red Flags","6a107870abd16353d20036c8","*   **Financials:** Consolidated revenue for FY26 grew 17.4% to ₹439 Cr. However, standalone profit was significantly boosted by a one-time exceptional gain of ₹40.6 Cr from a loan write-back.\n*   🔴 **Qualified Audit Opinion:** For the 3rd\u002F5th time on key issues, auditors issued a qualified opinion. They were unable to verify the recoverability of a massive ₹776 Cr receivable and noted the company has not provided for liabilities against invoked guarantees.\n*   🔴 **Going Concern Warning:** Auditors highlighted a \"Material Uncertainty Related to Going Concern,\" citing multiple invoked guarantees and large debts which cast \"significant doubt\" on the company's ability to continue operations.\n*   **Massive Liabilities:** The company faces huge obligations, including an outstanding amount of ₹663 Cr payable to Assets Care & Reconstruction Enterprise (ACRE) following a terminated settlement.\n*   **Segment Performance:** The core \"Educational services\" segment remains the sole profitable driver (PBIT of ₹78.6 Cr), while the \"Construction\" and \"Training\" segments continue to post losses.",{"company_name":317,"filing_date":318,"filing_source":9,"headline":319,"id":320,"stock_code":321,"summary_text":322},"Vandan Foods Ltd","2026-05-22T21:06:40.756000","FY26 Results: Revenue Soars 140%, But Profits Collapse & Company Swings to H2 Loss","6a1078550c6b4fb98a92b655","544436","- **Profitless Growth:** FY26 revenue grew 140% to ₹25,963 Lakhs, but Profit After Tax (PAT) collapsed 81% to ₹132 Lakhs as expenses surged 161%.\n- **H2 Performance Deterioration:** The company swung to a significant loss in the second half (H2 FY26), posting a Loss Before Tax of ₹420 Lakhs, a sharp reversal from a profit of ₹602 Lakhs in H1.\n- **Negative Operating Cash Flow:** A major red flag as Cash Flow from Operations worsened significantly to a negative (₹2,426 Lakhs), indicating the business is consuming large amounts of cash to operate.\n- **Working Capital Strain:** Inventories (+138%) and Trade Receivables (+353%) have ballooned, locking up significant cash and straining liquidity.\n- **Shareholder Impact:** Basic EPS plummeted 88% to ₹1.72 from ₹13.80 in FY25, following significant equity dilution from a ₹3,036 Lakhs capital raise.",{"company_name":324,"filing_date":325,"filing_source":9,"headline":326,"id":327,"stock_code":328,"summary_text":329},"Bacil Pharma Ltd","2026-05-22T21:06:40.726000","Disclosure of Nil Related Party Transactions","6a107829890e096a6fc61822","524516","*   The company has reported **\"Nil\" Related Party Transactions** for the half-year period ending March 31, 2026.\n*   This is a mandatory disclosure filed with the BSE under Regulation 23(9) of the SEBI LODR Regulations.\n*   The \"Nil\" report is considered a **positive signal for corporate governance**, suggesting an absence of potential conflicts of interest during the period.\n*   The filing was signed by Ms. Chaitali Kalpataru Shah, Director & CFO.",{"company_name":331,"filing_date":332,"filing_source":9,"headline":333,"id":334,"stock_code":335,"summary_text":336},"Sun Pharmaceutical Industries Ltd","2026-05-22T21:01:54","FY26 Q4 Earnings Call Audio Recording Released","6a107712ec7f5de862c5dbc1","SUNPHARMA","*   The audio recording for the FY26-Q4 earnings call, held on May 22, 2026, is now available on the company's corporate website.\n*   This filing is a procedural notification to inform investors where to access the recording, enhancing shareholder transparency.\n*   The document itself does not contain financial results or outlooks; substantive information is in the linked audio.\n*   No red flags are present in this filing, as it is a standard compliance disclosure.",{"company_name":41,"filing_date":338,"filing_source":9,"headline":339,"id":340,"stock_code":45,"summary_text":341},"2026-05-22T21:01:53.910000","FY26 Results: Revenue Grows 11% but Profit Falls 11% on Higher Costs; Dividend Maintained","6a10773aecaa861d94929e8b","*   \u003Cb>Mixed Financials:\u003C\u002Fb> For FY26, consolidated revenue grew 11.26% YoY to ₹112,184 Lakhs, but Profit After Tax (PAT) fell 11.31% to ₹7,566 Lakhs due to margin pressure from rising costs.\n*   \u003Cb>Dividend Declared:\u003C\u002Fb> The Board recommended a final dividend of ₹13.75 per share (275%), the same as the previous year, subject to shareholder approval.\n*   \u003Cb>Strategic Re-organization:\u003C\u002Fb> The company has restructured its business into a single \"Chemicals\" segment for reporting, which reduces financial disclosure on its different business verticals.\n*   \u003Cb>Weakened Cash Flow:\u003C\u002Fb> Net cash from operating activities declined by 14.43% year-over-year, reflecting weaker operational performance.\n*   \u003Cb>Divestment:\u003C\u002Fb> The company sold its investment in associate company Mobitrash Recycle Ventures Private Limited.",{"company_name":306,"filing_date":343,"filing_source":9,"headline":344,"id":345,"stock_code":298,"summary_text":346},"2026-05-22T21:01:53.753000","Strong FY26 Growth, Dividend Declared & Key Strategic Wins","6a10775abf8f716f13002115","*   Reported strong FY26 results with a 17.3% YoY increase in consolidated revenue to ₹9,128 Cr and a 31% rise in Net Profit.\n*   The Board recommended a final dividend of ₹1.00 per share for the financial year 2025-26, subject to shareholder approval.\n*   Completed key acquisitions of Shrimann Hospital (Jalandhar) & People Tree Hospital (Bengaluru) and secured full ownership of the 'Fortis' & 'Agilus' brands.\n*   Major uncertainty resolved with the successful completion of promoter IHH Healthcare's mandatory open offer.\n*   \u003Cb>Key Risk:\u003C\u002Fb> Auditor's report, while giving a clean opinion, includes an \"Emphasis of Matter\" highlighting ongoing high-profile regulatory investigations (SFIO, SEBI, CBI) and a potential court-ordered forensic audit.",{"company_name":324,"filing_date":348,"filing_source":9,"headline":349,"id":350,"stock_code":328,"summary_text":351},"2026-05-22T21:01:53.746000","Confirms No Fund Raising in Q4 FY26","6a10770a58d87443453a8135","• The company filed a \"nil\" Statement of Deviation or Variation for the quarter ended March 31, 2026.\n• It confirmed that no funds were raised through public issue, rights issue, preferential issue, or any other means during this period.\n• Consequently, the requirement to file a detailed fund utilization report is not applicable.\n• This indicates no equity dilution for shareholders from new capital-raising activities during the quarter.",{"company_name":353,"filing_date":348,"filing_source":9,"headline":354,"id":355,"stock_code":356,"summary_text":357},"Lemon Tree Hotels Ltd","New Investor Acquires 41% Stake in Subsidiary Fleur Hotels","6a107712c9cbead9b3c5ff53","LEMONTREE","*   A new investor, Coastal Cedar Investments B.V., has completed the acquisition of a 41.09% stake in the company's material subsidiary, Fleur Hotels Limited (FHL).\n*   Lemon Tree Hotels' own shareholding in FHL is not affected, and FHL remains a subsidiary of the company.\n*   The previous Shareholders' Agreement from 2012 has been terminated.\n*   A new Shareholders' Agreement is now in effect with the new investor, realigning the strategic partnership for FHL.",{"company_name":359,"filing_date":360,"filing_source":24,"headline":361,"id":362,"stock_code":363,"summary_text":364},"GAIL (India) Limited","2026-05-22T21:01:40.523000","FY26 Analyst Meet Recording Now Available","6a107700890e096a6fc61817","GAIL","*   GAIL has provided the audio\u002Fvideo recording link for its Investors' and Analysts' Meet held on May 22, 2026.\n*   The meeting was held to discuss the Audited Financial Results for the financial year 2026 (FY26).\n*   This disclosure enhances transparency by providing investors and stakeholders with direct access to management discussions and Q&A sessions.\n*   The filing is in compliance with Regulation 30 of the SEBI (LODR) Regulations, 2015.",{"company_name":366,"filing_date":367,"filing_source":24,"headline":368,"id":369,"stock_code":370,"summary_text":371},"Tata Steel Limited","2026-05-22T21:01:40.501000","Final Dividend Recommended: Key Dates & Tax Info","6a107710abd16353d20036c0","TATASTEEL","*   The Board has recommended a final dividend of **₹4 per Ordinary Share** for the financial year 2025-26, subject to shareholder approval.\n*   **Action Required:** Shareholders must update their records (PAN, bank details, etc.) by the record date to ensure the correct tax (TDS) is deducted.\n*   **Key Date:** The deadline for submitting documents is the record date, **Friday, June 12, 2026**.\n*   **Important:** Failure to provide a valid PAN may result in a higher tax deduction rate of **20%**.\n*   The dividend will be voted on at the AGM on **July 2, 2026**, with payment scheduled from **July 6, 2026**, if approved.",{"company_name":373,"filing_date":374,"filing_source":24,"headline":375,"id":376,"stock_code":335,"summary_text":377},"Sun Pharmaceutical Industries Limited","2026-05-22T21:01:40.472000","FY26-Q4 Earnings Call Recording Now Available","6a1076fa0c6b4fb98a92b64d","*   Sun Pharma has provided the audio recording for its investor earnings call held on May 22, 2026.\n*   This filing is a compliance update under SEBI regulations and does not contain new financial data.\n*   The recording provides access to management's discussion on FY26-Q4 performance and outlook.\n*   The audio can be accessed on the company's corporate website.",{"company_name":379,"filing_date":380,"filing_source":24,"headline":228,"id":381,"stock_code":382,"summary_text":383},"Anya Polytech & Fertilizers Limited","2026-05-22T21:01:40.450000","6a1076f8a157653c663a99e2","ANYA","*   A Board Meeting will be held on **May 30, 2026**, to approve the audited financial results for the year ended March 31, 2026.\n*   The trading window for all designated persons is closed from April 1, 2026, until 48 hours after the declaration of financial results.\n*   Investors should monitor the outcome of the meeting for the company's annual performance and any announcements under the \"Other business\" agenda.",{"company_name":385,"filing_date":386,"filing_source":9,"headline":387,"id":388,"stock_code":389,"summary_text":390},"Gail (India) Ltd","2026-05-22T20:56:41.279000","Recording of FY26 Financial Results Analyst Meet Now Public","6a1075df58d87443453a812e","532155","*   GAIL has provided the public link to the audio\u002Fvideo recording of its Investors' and Analysts' Meet held on May 22, 2026.\n*   The meet focused on the discussion of the company's Audited Financial Results for the financial year 2026 (FY26).\n*   This disclosure is made in compliance with SEBI regulations to enhance transparency for all stakeholders.\n*   The recording allows investors to directly access the management's discussion on the company's performance.",{"company_name":392,"filing_date":393,"filing_source":9,"headline":394,"id":395,"stock_code":396,"summary_text":397},"Emrock Corporation Ltd","2026-05-22T20:56:41.137000","Trading Window Closed Ahead of Fund Raising Proposal","6a1075dcc9cbead9b3c5ff4c","531676","*   The company has closed its trading window for insiders, effective May 22, 2026.\n*   This action is in preparation for an upcoming Board Meeting to consider and approve a fund-raising plan.\n*   The planned fund-raising is a significant event for shareholders, as it could result in equity dilution or increased debt.\n*   Details on the amount, method, and date of the Board Meeting for the fund raise were not disclosed in this specific filing and are awaited by investors.",{"company_name":306,"filing_date":399,"filing_source":9,"headline":400,"id":401,"stock_code":298,"summary_text":402},"2026-05-22T20:56:41.084000","FY26 Results: Strong Growth, Dividend Declared & Brand Ownership Secured","6a107636ecaa861d94929e86","*   **Financials:** Reports strong FY26 performance with 19% revenue growth in Healthcare and a significant 84% profit surge in the Diagnostics segment.\n*   **Dividend:** The Board has recommended a final dividend of ₹ 1.00 per equity share.\n*   **Strategic Win:** Successfully acquired ownership of the 'Fortis' and 'SRL' brands, securing long-term brand identity and eliminating licensing costs.\n*   **Expansion:** Completed acquisitions of 'People Tree Hospital' in Bengaluru and 'Shrimann Hospital' in Jalandhar to expand its hospital network.\n*   **Governance:** The mandatory open offer by promoter IHH Healthcare Berhad was completed, providing long-term stability to the shareholding structure.\n*   **Red Flag:** The auditor's report includes an 'Emphasis of Matter' highlighting ongoing investigations by SFIO, SEBI, and other agencies into the company's past.",{"company_name":404,"filing_date":405,"filing_source":9,"headline":406,"id":407,"stock_code":408,"summary_text":409},"Jubilant Pharmova Ltd","2026-05-22T20:56:41.075000","Q4 & FY26 Earnings Call Audio Now Available","6a1075d8bf8f716f1300210b","JUBLPHARMA","*   Jubilant Pharmova has uploaded the audio recording of its Earnings Webinar for the quarter and year ended March 31, 2026.\n*   This filing is a regulatory disclosure informing stock exchanges and investors about the availability of the recording.\n*   The document itself does not contain financial data but provides a direct link for stakeholders to listen to the management's discussion on performance.\n*   This action provides investors with direct access to the analysis of the company's financial results.",{"company_name":411,"filing_date":412,"filing_source":9,"headline":413,"id":414,"stock_code":415,"summary_text":416},"IIFL Finance Ltd","2026-05-22T20:56:40.991000","Compliance Report Highlights Subsidiary Fines & Past Governance Issues","6a1075f0a157653c663a99dc","IIFL","*   The company filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2026, which revealed several compliance lapses.\n*   A material subsidiary, IIFL Samasta Finance Ltd, was repeatedly fined by both NSE & BSE for multiple violations, including failure to provide advance notice of record dates.\n*   The report highlights a significant past governance lapse from FY 2024-25, where the company paid excess remuneration to the MD & Promoter without prior shareholder approval.\n*   The parent company was also fined in the previous year for delayed submission of annual financial results, indicating a pattern of compliance challenges.",{"company_name":179,"filing_date":418,"filing_source":9,"headline":419,"id":420,"stock_code":183,"summary_text":421},"2026-05-22T20:56:40.814000","FY26 Profit Slumps 29%, Appoints New Director from DuPont","6a1075dd890e096a6fc6180e","*   **Annual Profit Decline**: Net Profit After Tax (PAT) for FY26 fell by **28.85%** year-over-year to ₹1,042.75 Lakhs. Basic EPS dropped to ₹8.26 from ₹11.61.\n*   **Quarterly Performance**: For Q4 FY26, PAT plunged **51.15%** YoY to ₹198.73 Lakhs, despite an 11.31% increase in revenue. This was due to a sharp 42.45% surge in expenses.\n*   **Revenue**: Full-year revenue from operations decreased by 5.90% to ₹6,657.04 Lakhs.\n*   **Director Appointment**: The Board appointed **Mr. Vimal Mishra** as an Additional Director. He is a senior leader from DuPont with over 26 years of experience, currently leading the MULTIBASE™ business in South Asia.\n*   **Cash Position**: Cash and cash equivalents saw a healthy increase, standing at ₹6,212.25 Lakhs as of March 31, 2026.",{"company_name":279,"filing_date":423,"filing_source":9,"headline":424,"id":425,"stock_code":246,"summary_text":426},"2026-05-22T20:56:40.791000","Q4 & FY26 Earnings Call Recording Now Available","6a1075d80c6b4fb98a92b642","*   The audio recording of the earnings call for the quarter and year ended March 31, 2026, is now available on the company's website.\n*   The call was held on May 22, 2026, to discuss the audited financial results for the period.\n*   This filing is a procedural notification; the actual financial performance and management commentary are contained within the audio recording.",{"company_name":428,"filing_date":429,"filing_source":9,"headline":430,"id":431,"stock_code":432,"summary_text":433},"Hercules Investments Ltd","2026-05-22T20:56:40.703000","Board Meeting on May 28 to Approve FY26 Results & Consider Dividend","6a1075d9abd16353d20036b6","HERCULES","*   A Board Meeting is scheduled for May 28, 2026, to approve the audited financial results for the quarter and year ended March 31, 2026.\n*   The Board will also consider the recommendation of a final dividend for the financial year 2026.\n*   The trading window for insiders has been closed since April 01, 2026, and will reopen 48 hours after the results are declared.\n*   \u003Cb>Key Note:\u003C\u002Fb> The company's name has changed from \"Hercules Hoists Limited\" to \"HERCULES INVESTMENTS LIMITED,\" indicating a potential strategic shift from manufacturing to investment activities.",{"company_name":435,"filing_date":436,"filing_source":9,"headline":437,"id":438,"stock_code":439,"summary_text":440},"Balgopal Commercial Ltd","2026-05-22T20:51:41.737000","Announces Joint Development Agreement for Mumbai Real Estate Project","6a107508ec7f5de862c5dbb3","539834","• Enters a Joint Development Agreement (JDA) with M\u002Fs. Viraj Enterprises for a Slum Rehabilitation Authority (SRA) project in Juhu, Mumbai.\n• Balgopal will fund the entire project cost and receive an \u003Cb>85% share\u003C\u002Fb> of the net revenue from sales.\n• The company will pay a refundable, interest-free security deposit of \u003Cb>₹15 Crores\u003C\u002Fb> to Viraj Enterprises.\n• \u003Cb>Important:\u003C\u002Fb> This is a Related Party Transaction, as Balgopal's Promoter & MD is also a partner in Viraj Enterprises. The company states the deal is at arm's length and was pre-approved by shareholders.",{"company_name":442,"filing_date":443,"filing_source":9,"headline":444,"id":445,"stock_code":370,"summary_text":446},"Tata Steel Ltd","2026-05-22T20:51:41.732000","₹4\u002FShare Dividend Recommended & Key Dates Announced","6a107503ecaa861d94929e81","*   The Board has recommended a dividend of \u003Cb>₹4 per share\u003C\u002Fb> for the financial year 2025-26.\n*   The \u003Cb>Record Date\u003C\u002Fb> to be eligible for the dividend is set for \u003Cb>June 12, 2026\u003C\u002Fb>.\n*   Dividend payment will commence from \u003Cb>July 6, 2026\u003C\u002Fb>, subject to shareholder approval at the AGM on July 2, 2026.\n*   \u003Cb>Action Required:\u003C\u002Fb> Shareholders must update their PAN and other tax documents by the record date to avoid a higher TDS deduction of 20%.",{"company_name":448,"filing_date":449,"filing_source":9,"headline":450,"id":451,"stock_code":452,"summary_text":453},"SAB Events & Governance Now Media Ltd","2026-05-22T20:51:41.684000","Posts 'Nil' Deviation Secretarial Compliance Report for FY26","6a10750858d87443453a8129","SABEVENTS","\u003Cul>\n    \u003Cli>The company filed its Annual Secretarial Compliance Report for FY 2025-26, which showed \u003Cb>\"Nil\" deviations\u003C\u002Fb> from applicable SEBI regulations.\u003C\u002Fli>\n    \u003Cli>The report confirms that \u003Cb>no adverse actions were taken by SEBI or Stock Exchanges\u003C\u002Fb> against the company during the year.\u003C\u002Fli>\n    \u003Cli>It was also confirmed that \u003Cb>none of the company's directors are disqualified\u003C\u002Fb> and that the required board performance evaluation was conducted.\u003C\u002Fli>\n    \u003Cli>The filing noted that no buybacks, new share issues, or other specified corporate actions requiring compliance occurred during the year.\u003C\u002Fli>\n\u003C\u002Ful>",{"company_name":317,"filing_date":455,"filing_source":9,"headline":456,"id":457,"stock_code":321,"summary_text":458},"2026-05-22T20:51:41.624000","[Confirms No Deviation in Use of IPO Funds]","6a1074fb0c6b4fb98a92b634","*   The company confirmed \u003Cb>no deviation or variation\u003C\u002Fb> in the use of its IPO proceeds for the half-year ended March 31, 2026.\n*   A total of \u003Cb>₹30.26 Crores (99.65%)\u003C\u002Fb> out of the ₹30.36 Crores raised has been utilized, indicating strong execution against stated goals.\n*   Funds were deployed as planned for working capital, debt repayment, CAPEX for facility expansion, and general corporate purposes.\n*   The report was reviewed by the Audit Committee and certified by the statutory auditors, providing assurance to shareholders.",{"company_name":324,"filing_date":460,"filing_source":9,"headline":461,"id":462,"stock_code":328,"summary_text":463},"2026-05-22T20:51:41.568000","FY26 Results: Zero Operational Revenue, Auditor Flags Major Compliance Gap","6a1075055236ec99893a6289","*   **Zero Operational Revenue:** The company reported ₹0 in revenue from its core operations for the entire FY26. All income was generated from other sources.\n*   **Operations Halted:** The auditor's report explicitly confirms that \"there were no operations during the year,\" with the company's activities being primarily investment-based, not pharmaceutical.\n*   **Profit vs. Comprehensive Loss:** While Profit After Tax (PAT) was positive at ₹155.55 Lakhs, the Total Comprehensive Income was a loss of ₹(61.88) Lakhs due to large mark-to-market losses on financial investments.\n*   **Major Compliance Failure:** The auditor flagged a significant risk, stating the company does not use accounting software with a required audit trail (edit log) feature, a direct compliance violation.\n*   **Cash Drain:** Cash and cash equivalents fell sharply from ₹285.73 Lakhs to ₹56.85 Lakhs during the year, primarily used in investing activities.",{"company_name":465,"filing_date":466,"filing_source":9,"headline":467,"id":468,"stock_code":469,"summary_text":470},"GHV Infra Projects Ltd","2026-05-22T20:51:41.563000","FY26 Results: Revenue Skyrockets, But Cash Flow & EPS Under Pressure","6a1074fdbf8f716f13002102","505504","*   **Massive Growth:** For FY26, Revenue from Operations surged 227.5% to ₹60,553.10 Lakhs, and Net Profit grew 146.5% to ₹4,225.50 Lakhs.\n*   **EPS Dilution:** Despite the profit surge, Adjusted Basic EPS declined by 17.3% to ₹5.86 due to a bonus issue and share split during the year.\n*   **Major Red Flag:** The company reported deeply negative cash flow from operations for the second consecutive year (-₹5,437.94 Lakhs), indicating high reported profits are not converting to cash. Growth is being funded by a significant increase in debt.\n*   **Promoter Reclassification:** The Board approved a request to reclassify a 'Promoter Group' member to the 'Public Shareholder' category, subject to regulatory approval.\n*   **International Expansion:** The company has expanded into the UAE by incorporating a new wholly-owned subsidiary, GHV Infra FZ-LLC.",{"company_name":472,"filing_date":473,"filing_source":9,"headline":474,"id":475,"stock_code":476,"summary_text":477},"Colgate Palmolive (India) Ltd","2026-05-22T20:51:41.443000","Q4 Sales Rebound, But Full-Year Profit Declines 7.76%","6a1074e8890e096a6fc617ea","COLPAL","*   **Q4 FY26 Performance:** The company reported a strong rebound with Net Sales growing 9.0% YoY to ₹1,582.8 Crore. However, Net Profit saw a marginal decline of 0.48% YoY.\n*   **Annual FY26 Performance:** Despite the positive Q4, full-year Net Profit declined significantly by 7.76% to ₹1,325.3 Crore. Full-year Net Sales also dipped slightly by 0.26%.\n*   **Dividend Declared:** The Board has approved a second interim dividend of ₹24 per share, bringing the total dividend for the financial year 2026 to ₹48 per share.\n*   **Strategic Initiatives:** Announced a \"category-first\" marketing partnership with the Mumbai Indians cricket team and a large-scale community outreach program with the Government of Haryana.",{"company_name":306,"filing_date":479,"filing_source":9,"headline":480,"id":481,"stock_code":298,"summary_text":482},"2026-05-22T20:51:41.366000","FY26 Results: Revenue Jumps 17%, Dividend Announced & 'Fortis' Brand Acquired","6a107531a157653c663a99d8","*   Reports strong FY26 performance with a 17% YoY increase in net revenue and improved profitability across both Healthcare and Diagnostics segments.\n*   The Board has recommended a final dividend of ₹1.00 per equity share for the financial year 2025-26.\n*   Successfully acquired the 'Fortis' brand for ₹200 Crores and completed two hospital acquisitions, expanding its network.\n*   While the IHH Healthcare open offer was completed, the company remains under investigation by multiple agencies (SFIO, ED) for historical issues related to its former promoters, representing a key risk.",{"company_name":7,"filing_date":484,"filing_source":9,"headline":485,"id":486,"stock_code":12,"summary_text":487},"2026-05-22T20:51:41.188000","Q4 Profit Plummets 97% Amid Market Volatility","6a1074e9c9cbead9b3c5ff3e","*   \u003Cb>Drastic Profit Drop:\u003C\u002Fb> Q4 FY26 Profit After Tax (PAT) plummeted by 97.1% year-over-year to ₹0.2 crore. Full-year PAT also fell 30% to ₹73 crore.\n*   \u003Cb>Revenue Decline:\u003C\u002Fb> Consolidated income for FY26 fell 5.2% to ₹237 crore, with the Broking segment (-12.8%) hit harder than Merchant Banking (-2.6%).\n*   \u003Cb>Dividend Proposed:\u003C\u002Fb> The Board recommended a dividend of Re 1 per share (50%), subject to shareholder approval.\n*   \u003Cb>Strong Future Pipeline:\u003C\u002Fb> Despite the weak quarter, the company holds a robust pipeline of 25 IPO mandates, indicating potential for future recovery.\n*   \u003Cb>Healthy Cash Position:\u003C\u002Fb> Net cash improved to ₹311 crore from ₹242 crore in the previous year, showing strong cash management.",{"company_name":489,"filing_date":490,"filing_source":9,"headline":491,"id":492,"stock_code":493,"summary_text":494},"Chartered Logistics Ltd","2026-05-22T20:51:41.176000","Posts Net Loss for FY26 Due to One-Time Write-Off","6a1074f5f43b112c8d927927","531977","*   Reports a net loss of ₹226.53 Lakhs for FY26, a swing from a net profit of ₹138.68 Lakhs in FY25.\n*   The loss was primarily caused by a one-time, non-cash write-off of MAT Credit amounting to ₹140.01 Lakhs.\n*   Revenue from operations fell by 6.61% year-over-year to ₹7,154.76 Lakhs.\n*   Basic Earnings Per Share (EPS) turned negative to ₹(0.18) from ₹0.12 in the previous year.\n*   Acquired a 99.99% stake in a new subsidiary, \"Chartered Comcare IFSC Limited\".",{"company_name":496,"filing_date":497,"filing_source":9,"headline":498,"id":499,"stock_code":500,"summary_text":501},"Deccan Gold Mines Ltd","2026-05-22T20:51:41.135000","First Gold Revenue, Debt-Free Status & Major Nickel Discovery","6a1074f7f35e30561cfffbe0","512068","*   Jonnagiri mine becomes the first profitable asset, producing ~100 kg of gold. Deccan's share of projected FY27 profit from this mine is ~₹120 Crores.\n*   The company is now debt-free after repaying ₹219 Crores using proceeds from its recent ₹315 Crore rights issue.\n*   A major Nickel-Copper-PGE discovery was reported at the Bhalukona project in India, which management views as a key future value driver.\n*   The Altyn Tor gold mine in Kyrgyzstan is on track for full production by August 2026, projected to add ~₹60 Crores to Deccan's FY27 profit.\n*   Management projects a combined attributable profit of ~₹180 Crores for FY27 but requires an additional ₹60-100 Crores to complete the Kyrgyzstan project and ₹800-1,000 Crores for future growth.\n*   The high-potential Ganajur gold project remains stalled due to ongoing litigation, representing a key uncertainty.",{"company_name":503,"filing_date":504,"filing_source":24,"headline":505,"id":506,"stock_code":507,"summary_text":508},"Welspun Investments and Commercials Limited","2026-05-22T20:51:40.876000","Welspun Appoints New Internal Auditor","6a1074a8f43b112c8d927925","WELINV","*   The company has appointed M\u002Fs. Sureka Associates, Chartered Accountants, as its new Internal Auditor.\n*   The appointment is effective from April 1, 2026.\n*   This is a standard corporate governance measure aimed at strengthening the company's internal controls.",{"company_name":510,"filing_date":511,"filing_source":24,"headline":512,"id":513,"stock_code":514,"summary_text":515},"Surani Steel Tubes Limited","2026-05-22T20:51:40.686000","Board Meeting Rescheduled","6a1074d1ec7f5de862c5dbb1","SURANI","*   The Board of Directors meeting, originally scheduled for May 23, 2026, has been postponed and rescheduled to May 27, 2026.\n*   The reason for the postponement is the \"non-availability of KMP (Key Managerial Personnel).\"\n*   The agenda for the meeting includes considering the company's annual financial results.",{"company_name":517,"filing_date":518,"filing_source":24,"headline":519,"id":520,"stock_code":521,"summary_text":522},"MODISON LIMITED","2026-05-22T20:51:40.649000","Proposes 300% Final Dividend Amidst Filing Error","6a1074b65236ec99893a6287","MODISONLTD","*   The Board has recommended a Final Dividend of 300% (₹3.00 per share) for the financial year ended March 31, 2026.\n*   Payment is subject to shareholder approval at the upcoming 43rd Annual General Meeting (AGM).\n*   \u003Cb>Red Flag:\u003C\u002Fb> The official filing contains a significant clerical error, leaving the dividend rate blank in the descriptive text, which points to weak compliance reporting.\n*   The AGM date, Record Date for the dividend, and the payment date will be announced later.",{"company_name":524,"filing_date":525,"filing_source":24,"headline":526,"id":527,"stock_code":528,"summary_text":529},"Indigo Paints Limited","2026-05-22T20:51:40.508000","Appoints New Chief Business Officer to Drive Growth","6a1074afbf8f716f13002100","INDIGOPNTS","*   Appointed **Mr. Aishwarya Pratap Singh** as the new **Chief Business Officer**, a seasoned leader with 20 years of experience in Sales and Marketing at top FMCG firms, including a 17-year tenure at ITC Limited.\n*   Mr. Singh's appointment, with his background from IIM-Ahmedabad and IIT-Roorkee, signals a strategic focus on accelerating business growth and strengthening brand management.\n*   The company also formalized other key roles, appointing a GM - Finance, a new Internal Auditor (M\u002Fs. DKV & Associates), and a Cost Auditor (M\u002Fs. Harshad S Deshpande & Associates).\n*   These appointments are a positive development, aimed at strengthening the company's senior leadership, governance, and internal control framework.",{"company_name":198,"filing_date":531,"filing_source":24,"headline":532,"id":533,"stock_code":202,"summary_text":534},"2026-05-22T20:51:40.423000","GTBL Announces Transformative ~₹1,300 Cr Acquisition in Japan","6a1074c8ecaa861d94929e7f","*   Signed a definitive agreement to acquire 100% of Japan-based MicroBiopharm Japan Co., Ltd. (MBJ), a leading CDMO.\n*   The total consideration for the acquisition is approximately JPY 21.5 billion (~₹1,300 crores), to be funded via a mix of debt and equity.\n*   This is a transformative strategic move, evolving GTBL into a global, technology-driven CDMO platform with access to the Japanese market.\n*   The acquisition is expected to be EPS accretive and provides access to proprietary technologies and three manufacturing sites in Japan.\n*   The transaction is expected to close during Q2 of FY27, subject to customary approvals.",{"company_name":503,"filing_date":536,"filing_source":24,"headline":147,"id":537,"stock_code":507,"summary_text":538},"2026-05-22T20:51:40.382000","6a1074abc9cbead9b3c5ff3c","*   The company has appointed M\u002Fs. Sureka Associates, Chartered Accountants, as its new Internal Auditor.\n*   The appointment is effective from April 1, 2026.\n*   M\u002Fs. Sureka Associates, established in 1982, is an experienced firm with expertise in statutory, tax, and internal audits.",{"company_name":22,"filing_date":540,"filing_source":24,"headline":541,"id":542,"stock_code":12,"summary_text":543},"2026-05-22T20:51:40.263000","Reports Sharp Profit Decline; Declares Dividend Amid Market Headwinds","6a1074be58d87443453a8127","*   \u003Cb>Profit Plummets:\u003C\u002Fb> Q4 FY26 Profit After Tax (PAT) dropped 97.1% year-over-year to ₹0.25 crore. Full-year PAT fell 29.96% to ₹73 crore.\n*   \u003Cb>Revenue Decline:\u003C\u002Fb> Consolidated total income for FY26 decreased by 5.2% to ₹237 crore, impacted by a slowdown in IPO activity and market volatility.\n*   \u003Cb>Dividend Declared:\u003C\u002Fb> The Board has recommended a dividend of Re 1 per share (50% of face value), subject to shareholder approval.\n*   \u003Cb>Strong Future Pipeline:\u003C\u002Fb> Despite the weak quarter, the company has a robust pipeline of 25 IPO mandates, providing visibility for future growth.\n*   \u003Cb>Healthy Cash Position:\u003C\u002Fb> Net cash position increased to ₹311 crore from ₹242 crore in the previous year, providing a solid financial cushion.",{"company_name":294,"filing_date":545,"filing_source":24,"headline":546,"id":547,"stock_code":298,"summary_text":548},"2026-05-22T20:51:40.147000","Strong FY26 Growth; Key Overhangs Resolved with IHH Offer Completion & Brand Acquisition","6a10751babd16353d20036b2","*   **Strong Financials:** Reports robust FY26 results with consolidated revenue up 17.3% YoY to ₹9,128 Cr and PBIT up 36.0% to ₹1,636 Cr. Profitability improved significantly across both Healthcare and Diagnostics segments.\n*   **IHH Open Offer Completed:** The long-stalled mandatory open offer by parent company IHH Healthcare was completed on Nov 10, 2025, resolving a major uncertainty and a significant overhang on the stock.\n*   **Brand Ownership Secured:** Successfully acquired the 'Fortis' and 'SRL' brands through a court-mandated auction, ending a long-standing legal issue and securing brand rights for the future.\n*   **Dividend Declared:** The Board recommended a final dividend of ₹1.00 per equity share for the financial year 2025-26.\n*   **Strategic Expansion:** Continued its growth strategy by acquiring People Tree Hospital in Bengaluru and Shrimann Superspecialty Hospital in Jalandhar.\n*   **Key Risks Remain:** Ongoing investigations by SFIO\u002FEOW and a pending court matter regarding a potential forensic audit (related to erstwhile promoters) remain the primary risks to monitor.",{"company_name":198,"filing_date":550,"filing_source":24,"headline":551,"id":552,"stock_code":202,"summary_text":553},"2026-05-22T20:51:40.052000","To Acquire 100% of Japan's MicroBiopharm for ~₹1,300 Crore","6a1074b80c6b4fb98a92b632","*   Gujarat Themis Biosyn Limited (GTBL) will acquire 100% equity in MicroBiopharm Japan Co., Ltd. (MBJ), a company specializing in fermentation and CDMO services.\n*   The total consideration for the acquisition is **JPY 21.5 Billion (~₹1,300 Crore)**, funded through a mix of debt and equity.\n*   The transaction is **expected to be EPS accretive** and is anticipated to close in Q2 FY2027 (July-September 2026).\n*   This strategic move aims to transform GTBL into a globally integrated CDMO, leveraging MBJ's advanced biologics capabilities and its relationships with global pharma companies.\n*   The target company, MBJ, has a projected revenue of JPY 9.5 Billion (~₹570 Crore) for FY26.",{"company_name":555,"filing_date":556,"filing_source":24,"headline":557,"id":558,"stock_code":408,"summary_text":559},"Jubilant Pharmova Limited","2026-05-22T20:51:39.958000","Q4 & FY26 Earnings Call Recording Posted","6a1074ae890e096a6fc617e8","*   The company has uploaded the audio recording of its earnings webinar for the quarter and year ended March 31, 2026.\n*   This filing is a procedural notification and does not contain financial data; it only informs that the recording is available on the company's website.\n*   Investors should listen to the audio recording to access management's discussion and analysis of the financial results.",{"company_name":517,"filing_date":561,"filing_source":24,"headline":562,"id":563,"stock_code":521,"summary_text":564},"2026-05-22T20:51:39.916000","Board Recommends 300% Final Dividend","6a1074aca157653c663a99d6","*   The Board of Directors has recommended a Final Dividend of 300% (implying Rs. 3.00 per share) for the financial year 2025-2026.\n*   This dividend is subject to shareholder approval at the upcoming 43rd Annual General Meeting (AGM).\n*   **Red Flag:** The company's filing is materially incomplete, as the dividend amount per share is left blank (\"Rs. __\u002F-\"), creating ambiguity despite the 300% rate.\n*   The dates for the AGM, record date, and dividend payment will be announced in due course.",{"company_name":465,"filing_date":566,"filing_source":9,"headline":567,"id":568,"stock_code":469,"summary_text":569},"2026-05-22T20:46:41.780000","[FY26 Results: Revenue Soars 227%, But Cash Flow & EPS Raise Concerns]","6a1073dac9cbead9b3c5ff38","*   Revenue from operations grew 227.5% to ₹60,553.10 Lakhs, while Net Profit rose 146.5% to ₹4,225.50 Lakhs.\n*   Reported negative Cash Flow from Operations of (₹5,437.94) Lakhs for the second consecutive year, a significant red flag.\n*   Adjusted Basic EPS declined 17.3% to ₹5.86, diluted by a bonus issue and share sub-division.\n*   Expansion was heavily funded by debt, with total borrowings increasing significantly to ₹19,161.45 Lakhs.\n*   The Board approved a promoter's request to be reclassified as a public shareholder, pending regulatory approval.\n*   Statutory auditors issued an unmodified (clean) opinion on the financial results.",{"company_name":571,"filing_date":572,"filing_source":9,"headline":573,"id":574,"stock_code":575,"summary_text":576},"Paradeep Parivahan Ltd","2026-05-22T20:46:41.690000","Strengthens Governance with New Insider Trading Policy","6a10738df43b112c8d92791a","544383","*   The company has adopted a new \"Code of Fair Disclosure\" for Unpublished Price Sensitive Information (UPSI) to comply with SEBI regulations.\n*   A key feature is the creation of a structured digital database to track and log all individuals who receive UPSI, enhancing accountability.\n*   The policy, effective May 22, 2026, aims to ensure prompt, uniform, and non-discriminatory disclosure of information to protect shareholder interests.\n*   A Chief Investor Relation Officer has been designated to oversee the process, with contact at `cfo@paradeepparivahan.com`.",{"company_name":578,"filing_date":579,"filing_source":9,"headline":580,"id":581,"stock_code":582,"summary_text":583},"Vikran Engineering Ltd","2026-05-22T20:46:41.674000","FY26 Revenue Soars 36%, But Profit Margins Decline","6a1073965236ec99893a6281","544496","*   **Strong Revenue Growth:** Full-year (FY26) revenue from operations jumped 36.4% to ₹1,249.3 crores, while Q4 FY26 revenue grew 82.2% YoY.\n*   **Margin Squeeze:** A key concern is the decline in profitability. FY26 EBITDA margin fell by 350 bps to 14.0%, and PAT margin dropped by 120 bps to 7.3%.\n*   **Record Order Book:** The company reported a robust order book of ₹5,737 crores, providing strong revenue visibility. The Solar segment is now the largest contributor at 49%.\n*   **Strategic Solar Push:** Completed the 100% acquisition of NOPL Solar Projects Private Limited, strengthening its position in the renewable energy sector.\n*   **Future Outlook:** Management is focusing on \"margin improvement\" and plans to expand into the high-growth Data Centre segment in FY27.",{"company_name":324,"filing_date":585,"filing_source":9,"headline":586,"id":587,"stock_code":328,"summary_text":588},"2026-05-22T20:46:41.492000","Reports FY26 Profit Despite Zero Operational Revenue","6a107397ecaa861d94929e78","*   The company reported a net profit of ₹155.55 Lakhs for FY26, a turnaround from a loss of ₹6.17 Lakhs in the previous year.\n*   However, this was achieved with **zero revenue from its core operations**. The profit was driven entirely by 'Other Income' (₹123.52 Lakhs) and a tax credit.\n*   **[RED FLAG]** The auditor noted a major compliance failure: the company is not using accounting software with a mandatory audit trail (edit log) feature.\n*   The business is currently functioning more as an investment holding company than a pharmaceutical entity, with management providing no concrete plans for restarting operations.",{"company_name":489,"filing_date":590,"filing_source":9,"headline":591,"id":592,"stock_code":493,"summary_text":593},"2026-05-22T20:46:41.444000","Swings to Net Loss for FY26, Cites One-Time Tax Expense","6a1073baf35e30561cfffbdb","*   Reports a Standalone Net Loss of ₹226.53 Lakhs for FY26, a sharp reversal from a Net Profit of ₹138.68 Lakhs in the previous year.\n*   The loss was significantly impacted by a one-time, non-cash tax expense of ₹140.01 Lakhs due to the write-off of MAT Credit.\n*   Revenue from operations declined by 6.6% year-over-year to ₹7,154.76 Lakhs.\n*   Despite the accounting loss, the company generated positive Net Cash Flow from Operating Activities of ₹494.17 Lakhs.\n*   The company acquired a 99.99% stake in a new subsidiary, \"Chartered Comcare IFSC limited,\" and has published its first consolidated results.",{"company_name":595,"filing_date":596,"filing_source":9,"headline":597,"id":598,"stock_code":202,"summary_text":599},"Gujarat Themis Biosyn Ltd","2026-05-22T20:46:41.378000","To Acquire Japanese Pharma Firm for ~₹1,300 Crores","6a107395ec7f5de862c5dbac","*   Gujarat Themis Biosyn Ltd (GTBL) has signed a definitive agreement to acquire 100% of Japan-based MicroBiopharm Japan Co., Ltd. (MBJ).\n*   The total consideration for the acquisition is approximately JPY 21.5 billion (approx. ₹1,300 crores), to be funded via a mix of debt and equity.\n*   This acquisition marks a strategic transformation for GTBL, evolving it into a global, technology-driven Contract Development Manufacturing Organization (CDMO).\n*   The deal is expected to be EPS accretive (increase earnings per share) and is anticipated to close during Q2FY27.",{"company_name":595,"filing_date":601,"filing_source":9,"headline":602,"id":603,"stock_code":202,"summary_text":604},"2026-05-22T20:46:41.346000","Acquires 100% of Japan's MicroBiopharm in a ~₹1,300 Cr Deal","6a10739058d87443453a811a","*   \u003Cb>What:\u003C\u002Fb> The company is acquiring 100% equity in MicroBiopharm Japan Co., Ltd. (MBJ), a 60-year-old fermentation-based CDMO.\n*   \u003Cb>Deal Value:\u003C\u002Fb> The total consideration for the acquisition is JPY 21.5 Billion (~₹1,300 Crore).\n*   \u003Cb>Funding & Impact:\u003C\u002Fb> The transaction will be funded by a mix of debt and equity and is expected to be EPS accretive.\n*   \u003Cb>Strategic Goal:\u003C\u002Fb> The acquisition is a key step to becoming a \"Fermentation-based Globally Integrated CDMO,\" gaining access to precision fermentation, biologics, and a regulated manufacturing footprint in Japan with 3 GMP-compliant plants.\n*   \u003Cb>Timeline:\u003C\u002Fb> The deal is expected to close in Q2 FY2027, subject to regulatory approvals.",{"company_name":606,"filing_date":607,"filing_source":24,"headline":608,"id":609,"stock_code":610,"summary_text":611},"Ashapura Logistics Limited","2026-05-22T20:46:40.617000","Mixed FY26 Results: Revenue Soars 38%, Profits Fall 20%","6a1073bebf8f716f130020fb","ASHALOG","*   \u003Cb>Top-Line vs. Bottom-Line:\u003C\u002Fb> Consolidated Revenue grew 38% YoY to ₹31,858 Lakhs, but Consolidated Profit Before Tax (PBT) fell 20% to ₹1,331 Lakhs, indicating severe margin pressure.\n*   \u003Cb>EPS Decline:\u003C\u002Fb> Basic Earnings Per Share (EPS) dropped significantly from ₹10.06 in the previous year to ₹6.65.\n*   \u003Cb>IPO Funds Deployed:\u003C\u002Fb> The company has fully utilized its IPO proceeds of ₹4,766 Lakhs for capacity expansion (vehicles & warehouses), completing the strategic initiatives outlined in its prospectus.\n*   \u003Cb>Key Red Flag:\u003C\u002Fb> The sharp decline in profitability despite robust sales growth is a major concern, driven by rising costs and poor performance in the company's largest revenue segment (Gujarat).\n*   \u003Cb>Clean Audit Report:\u003C\u002Fb> The statutory auditor issued an 'Unmodified Opinion' on the financial statements for FY26.",true,100,3,3267]